Monica Cheng

Dr. Monica Cheng is a worldwide partnering contact, serving as Business Development and Licensing executive for Boehringer Ingelheim in CardioMetabolic Diseases. With global R&D centers, and capabilities in both small molecules and biotherapeutics, Boehringer Ingelheim's broad expertise in scaling concepts to marketed execution is substantial.

Dr. Cheng has been a mentor for BioHealthWays since February 2017, and has introduced us to Boehringer Ingelheim's many research interests in CardioMetabolic Diseases. An intersection between BioHealthWay's product focus and Boehringer Ingelheim's collaborative research opportunities is in Diabetic Retinopathy (macular edema, neuronal dysfunction, vascular dysfunction, neoangiogenesis). We are excited to be Dr. Cheng's mentee, as her experience and guidance is highly valuable.